Medical Oncologist | Research fellow @DFCI_BreastOnc | PhD student Translational Genomics @idibaps | @SOLTIyoung member | 🧬 Main focus: IO&breast cancer
We are so incredibly lucky to work with the superstar @tess_omeara! She is multitalented-- an incredible colleague, absolutely wonderful with patients, and able to analyze complex single-cell data!
@DFCI_BreastOnc
Metastasis kills most cancer patients and grows from invisible seeds. How do these seeds escape from attack by immune cells? These seeds harness stress hormones!🤯
thanks to @nyscf @parkerici for their support. Today at @Nature https://t.co/rMKnHEqQwb
Today, let’s talk triple-negative breast cancer 🎬
In this third video of SOLTI Young Perspectives, experts Elia Seguí (@elia_segui), MD (Dana-Farber Cancer Institute, 4CB) and Rodrigo Sánchez-Bayona (@Rodrosb), MD PhD (Hosp Univ 12 Octubre) share the latest updates, challenges, and controversies in this field.
Find out more on our YouTube channel 🔗 https://t.co/lKsCqVomeG
This project is supported by a grant from Daiichi-Sankyo Europe GmbH (@EUdaiichisankyo)
#beSOLTI #SYPerspectives #SABCS25 #breastcancer
Insights, debates, and practical takeaways, brought to you by SOLTI Young Perspectives! 🎬
Today, Elia Seguí (@elia_segui), MD (Dana-Farber Cancer Institute, 4CB) and Benjamin Walbaum (@benjiwal), MD (Hospital Clínico Universidad Católica de Chile) engage in an insightful discussion on luminal breast cancer treatment.
Don’t miss the full conversation 🔗 https://t.co/22Lhkeanrt
This project is supported by a grant from Daiichi-Sankyo Europe GmbH
#beSOLTI #SYPerspectives #SABCS25 #breastcancer
@TumorBoardTues@PTarantinoMD@IntegrityCE@elmayermd@MichaelGnant 24/32 #TumorBoardTuesday
🧑🏫Mini Tweetorial🧑🏫
🧬ctDNA/MRD: Future of selection?
🔹In eBC, ctDNA/MRD detection is strongly associated with recurrence
🔹But, benefit of intervening based on ctDNA/MRD unproven
🤔Can ctDNA help ID pts who may still do very well with ET alone?